Martin Shkreli, Who Raised An HIV Drug 5,000 Percent, Goes To Trial, Faces 20 Years In Jail
Martin Shkreli is set to stand trial in a New York federal court Monday for security fraud. The notorious former CEO of Turing Pharmaceuticals has been accused of running a Ponzi scheme and could face up to 20 years in prison if convicted.
In addition to security fraud, the 34-year-old is accused of wire fraud, conspiracy, and mismanaging money at his investment funds Elea Capital, MSMB Capital, MSMB Healthcare, as well as while CEO of Retrophin (RTRX), the pharmaceutical company he founded in 2011.